-
asia Japanese authorities order Kobayashi Pharma to recall red yeast rice pills after 2 deaths
28 Mar 2024 09:31 GMT
TOKYO — Japanese authorities on Wednesday (March 27) ordered drugmaker Kobayashi Pharmaceutical to recall three dietary supplement products containing red yeast rice, or beni koji, after they were linked to two deaths.
More than 100 people have been …
-
These health products were thought to lower cholesterol. Now there is a feared link to kidney dysfunction
28 Mar 2024 08:00 GMT
… by Osaka-based Kobayashi Pharmaceutical.
All three supplements contain … Pharmaceutical said all four deceased users had suffered from kidney … them had been taking the pills since 2021, when the … island’s Food and Drug Administration ordered distributors to …
-
Muthiah “Muthu” Vaduganathan Discusses the Role of SGLT2 Inhibitors in Heart Failure Treatment
28 Mar 2024 04:56 GMT
Muthiah “Muthu” Vaduganathan MD, MPH, consultant cardiologist at Brigham and Women's Hospital and a member of faculty at Harvard Medical School, discusses the evolving treatment landscape for heart failure, emphasizing the use of SGLT2 inhibitors …
-
FDA approves Akebia's anemia drug after saying no in 2022
28 Mar 2024 04:49 GMT
… FDA on Wednesday greenlit Akebia Therapeutics’ treatment for anemia due to chronic kidney … disease, marking a turnaround for vadadustat, which the FDA rejected …
-
Akebia's Vafseo Tablets Approved By FDA For Anemia Treatment In Dialysis Patients
28 Mar 2024 02:31 GMT
Akebia Therapeutics Inc. (AKBA) said that the U.S. Food and Drug Administration has approved Vafseo or vadadustat Tablets for the treatment of anemia due to chronic kidney disease or CKD in adults who have been receiving dialysis for at least three months. …
-
Two years after initial rejection, Akebia’s anemia drug finally gets FDA approval
28 Mar 2024 01:41 GMT
… Drug Administration over a drug it developed for anemia in patients with chronic kidney … FDA approved vadadustat, which will be marketed as Vafseo, for the treatment … The drug is a once-a-day oral pill.
Akebia … on a medley of drugs, including vadadustat.
“We …
-
Researchers develop a risk prediction model for cisplatin-induced kidney damage
28 Mar 2024 01:39 GMT
… moderate-to-severe kidney injury after receiving the chemotherapy drug cisplatin in … discontinuation of life-saving cancer treatments. Investigators from Brigham and Women … 20-fold higher risk of developing kidney injury after cisplatin than those …
-
Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis
28 Mar 2024 01:37 GMT
… Drug Administration (FDA) has approved Vafseo® (vadadustat) Tablets for the treatment … development programs for Vafseo.
Lori Hartwell, who has had kidney … levels.
No trial has identified a hemoglobin … BOXED WARNING and Medication Guide.
Forward-Looking …
-
FDA Approves Vadadustat (Vafseo) Tablets for Anemia Due to CKD in Adult Patients on Dialysis
28 Mar 2024 01:09 GMT
… Food and Drug Administration (FDA) has approved vadadustat (Vafseo) for the treatment of … anemia due to chronic kidney disease (CKD … who participated in our clinical trials that led to this important …
-
U.S. FDA approves Akebia's anemia drug
28 Mar 2024 00:53 GMT
… The U.S. Food and Drug Administration approved Akebia Therapeutics… ; drug to treat anemia caused by chronic kidney disease in … dialysis patients, the drugmaker said on …